Showing 221 - 240 results of 391 for search '(( significant decrease decrease ) OR ( significant bins decrease ))~', query time: 0.39s Refine Results
  1. 221
  2. 222
  3. 223
  4. 224
  5. 225
  6. 226

    Table 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.docx by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
  7. 227

    Image 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
  8. 228

    Image 2_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
  9. 229
  10. 230
  11. 231
  12. 232
  13. 233
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238
  19. 239
  20. 240